Key facts
as of Sep 2026- Aescape’s last known valuation is $230.7M (Mar 2025).
- It has raised $130.7M across 1 recorded rounds; the latest was Early Stage VC ($33.7M) in Nov 2022.
- Notable investors include Alumni Ventures, Gaingels, AlleyCorp, Fifth Wall, Crosslink Capital — 52 tracked in total.
- Private Market View tracks 1 recorded secondary trades in Aescape shares.
- Aescape has filed 1 Form D with the SEC, most recently Nov 2022 ($33.7M sold to 25 investors).
- Status: Privately Held (backing).
PA Mark — composite indicative price
LOW confidence~$18per share
as of Sep 2026 · the exact daily mark is a member feature
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 52 names
- ·Watchlist + deal alerts for Aescape
Create free account
No card required
Recorded secondary trades
1 on record · Mar 2026 – Mar 20261 trades between Mar 2026 and Mar 2026. Exact dates, prices and structures are available to Pro members.
Mar 2026peak 1 prints / monthMar 2026
Counts and months are public. The prints are the product.Unlock 1 trade prints
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Aescape in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.
Funding rounds
1 roundsAbout Aescape
Developer of a robotics-driven technology designed to help people create a relationship with their bodies. The company's technology automates soft tissue treatment and brings actionable measurements to massage therapy using a system of sensing and artificial intelligence (AI), enabling users to undergo intelligent and personalized wellness experiences to improve their daily lives.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2017
- Employees
- 159
- Website
- aescape.com/
- Ownership
- Privately Held (backing)